Search

Mary Mosher

Examiner (ID: 10578)

Most Active Art Unit
1648
Art Unit(s)
1641, 1805, 2899, 1813, 1648, 1804, 1643, 1815, 1609
Total Applications
1434
Issued Applications
907
Pending Applications
126
Abandoned Applications
404

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 314534 [patent_doc_number] => 07524503 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-28 [patent_title] => 'Human cytomegalovirus (HCMV) cytotoxic T cell epitopes, polyepitopes compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor' [patent_app_type] => utility [patent_app_number] => 10/482284 [patent_app_country] => US [patent_app_date] => 2002-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 34925 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/524/07524503.pdf [firstpage_image] =>[orig_patent_app_number] => 10482284 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/482284
Human cytomegalovirus (HCMV) cytotoxic T cell epitopes, polyepitopes compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor Jun 25, 2002 Issued
Array ( [id] => 891615 [patent_doc_number] => 07344872 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-18 [patent_title] => 'Method for rapid screening of bacterial transformants and novel simian adenovirus proteins' [patent_app_type] => utility [patent_app_number] => 10/477527 [patent_app_country] => US [patent_app_date] => 2002-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19906 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/344/07344872.pdf [firstpage_image] =>[orig_patent_app_number] => 10477527 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/477527
Method for rapid screening of bacterial transformants and novel simian adenovirus proteins Jun 19, 2002 Issued
Array ( [id] => 6693169 [patent_doc_number] => 20030040601 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-27 [patent_title] => 'Method for making insulin precursors and insulin analog precursors' [patent_app_type] => new [patent_app_number] => 10/166241 [patent_app_country] => US [patent_app_date] => 2002-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6270 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20030040601.pdf [firstpage_image] =>[orig_patent_app_number] => 10166241 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/166241
Method for making insulin precursors and insulin analog precursors Jun 6, 2002 Abandoned
Array ( [id] => 6905487 [patent_doc_number] => 20050100882 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'CAPPING ENZYME OF FLAVIVIRUS AND UTILIZATION OF THIS PROTEIN IN A PROCESS TO TEST DRUGS WITH ANTIVIRAL PROPERTIES' [patent_app_type] => utility [patent_app_number] => 10/160821 [patent_app_country] => US [patent_app_date] => 2002-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6905 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20050100882.pdf [firstpage_image] =>[orig_patent_app_number] => 10160821 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/160821
Capping enzyme of flavivirus and utilization of this protein in a process to test drugs with antiviral properties May 30, 2002 Issued
Array ( [id] => 6744622 [patent_doc_number] => 20030021805 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Generation of HCV-like particles and chimeric HCV virus' [patent_app_type] => new [patent_app_number] => 10/156647 [patent_app_country] => US [patent_app_date] => 2002-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 6921 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20030021805.pdf [firstpage_image] =>[orig_patent_app_number] => 10156647 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/156647
Generation of HCV-like particles and chimeric HCV virus May 28, 2002 Abandoned
Array ( [id] => 5743099 [patent_doc_number] => 20060088824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Wnv core protein/capsid interacting protein and uses of the same' [patent_app_type] => utility [patent_app_number] => 10/478743 [patent_app_country] => US [patent_app_date] => 2002-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5594 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20060088824.pdf [firstpage_image] =>[orig_patent_app_number] => 10478743 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/478743
WNV core protein/capsid interacting protein and uses of the same May 27, 2002 Issued
Array ( [id] => 6778183 [patent_doc_number] => 20030049264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Clostridial toxin derivatives able to modify peripheral sensory afferent functions' [patent_app_type] => new [patent_app_number] => 10/150262 [patent_app_country] => US [patent_app_date] => 2002-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8734 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 196 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20030049264.pdf [firstpage_image] =>[orig_patent_app_number] => 10150262 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/150262
Clostridial toxin derivatives able to modify peripheral sensory afferent functions May 19, 2002 Issued
Array ( [id] => 6688311 [patent_doc_number] => 20030032036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Novel bacteriophage, a process for the islolation thereof, and a universal growth medium useful in the process thereof' [patent_app_type] => new [patent_app_number] => 10/144457 [patent_app_country] => US [patent_app_date] => 2002-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11755 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20030032036.pdf [firstpage_image] =>[orig_patent_app_number] => 10144457 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/144457
Bacteriophage, a process for the isolation thereof, and a universal growth medium useful in the process thereof May 12, 2002 Issued
Array ( [id] => 6687958 [patent_doc_number] => 20030031683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Recombinant vaccines comprising immunogenic attenuated bacteria having RpoS positive phenotype' [patent_app_type] => new [patent_app_number] => 10/138239 [patent_app_country] => US [patent_app_date] => 2002-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 32874 [patent_no_of_claims] => 86 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20030031683.pdf [firstpage_image] =>[orig_patent_app_number] => 10138239 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/138239
Recombinant vaccines comprising immunogenic attenuated bacteria having RpoS positive phenotype May 2, 2002 Issued
Array ( [id] => 1311346 [patent_doc_number] => 06610474 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-26 [patent_title] => 'Cells for detection of influenza and parainfluenza viruses' [patent_app_type] => B1 [patent_app_number] => 10/133910 [patent_app_country] => US [patent_app_date] => 2002-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13204 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/610/06610474.pdf [firstpage_image] =>[orig_patent_app_number] => 10133910 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/133910
Cells for detection of influenza and parainfluenza viruses Apr 24, 2002 Issued
Array ( [id] => 718840 [patent_doc_number] => 07048930 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-23 [patent_title] => 'Expression of core-glycosylated HCV envelope proteins in yeast' [patent_app_type] => utility [patent_app_number] => 10/128578 [patent_app_country] => US [patent_app_date] => 2002-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 54 [patent_no_of_words] => 34128 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/048/07048930.pdf [firstpage_image] =>[orig_patent_app_number] => 10128578 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/128578
Expression of core-glycosylated HCV envelope proteins in yeast Apr 23, 2002 Issued
Array ( [id] => 6765532 [patent_doc_number] => 20030099931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => 'Prophylactic and therapeutic monoclonal antibodies' [patent_app_type] => new [patent_app_number] => 10/127641 [patent_app_country] => US [patent_app_date] => 2002-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7966 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20030099931.pdf [firstpage_image] =>[orig_patent_app_number] => 10127641 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/127641
Prophylactic and therapeutic monoclonal antibodies Apr 21, 2002 Issued
Array ( [id] => 1166086 [patent_doc_number] => 06752995 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-06-22 [patent_title] => 'Nucleic acid and polypeptide sequences useful as adjuvants' [patent_app_type] => B2 [patent_app_number] => 10/123058 [patent_app_country] => US [patent_app_date] => 2002-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 15812 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/752/06752995.pdf [firstpage_image] =>[orig_patent_app_number] => 10123058 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/123058
Nucleic acid and polypeptide sequences useful as adjuvants Apr 14, 2002 Issued
Array ( [id] => 307115 [patent_doc_number] => 07531180 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-12 [patent_title] => 'Chimeric alphavirus replicon particles' [patent_app_type] => utility [patent_app_number] => 10/123101 [patent_app_country] => US [patent_app_date] => 2002-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 12 [patent_no_of_words] => 30593 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/531/07531180.pdf [firstpage_image] =>[orig_patent_app_number] => 10123101 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/123101
Chimeric alphavirus replicon particles Apr 10, 2002 Issued
Array ( [id] => 6643017 [patent_doc_number] => 20030104008 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Recombinant vaccine against west nile virus' [patent_app_type] => new [patent_app_number] => 10/116298 [patent_app_country] => US [patent_app_date] => 2002-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14240 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20030104008.pdf [firstpage_image] =>[orig_patent_app_number] => 10116298 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/116298
Recombinant vaccine against west nile virus Apr 3, 2002 Abandoned
Array ( [id] => 1132534 [patent_doc_number] => 06783759 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-31 [patent_title] => 'Compositions and methods for modulating variola virus' [patent_app_type] => B2 [patent_app_number] => 10/108311 [patent_app_country] => US [patent_app_date] => 2002-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10102 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/783/06783759.pdf [firstpage_image] =>[orig_patent_app_number] => 10108311 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/108311
Compositions and methods for modulating variola virus Mar 26, 2002 Issued
Array ( [id] => 633861 [patent_doc_number] => 07128916 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-31 [patent_title] => 'Bacteriophage-mediated immunisation' [patent_app_type] => utility [patent_app_number] => 10/473664 [patent_app_country] => US [patent_app_date] => 2002-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 6539 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/128/07128916.pdf [firstpage_image] =>[orig_patent_app_number] => 10473664 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/473664
Bacteriophage-mediated immunisation Mar 24, 2002 Issued
Array ( [id] => 6048033 [patent_doc_number] => 20020168760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => 'Retroviral vectors for gene transfer into neuronal cells' [patent_app_type] => new [patent_app_number] => 10/097556 [patent_app_country] => US [patent_app_date] => 2002-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5872 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20020168760.pdf [firstpage_image] =>[orig_patent_app_number] => 10097556 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/097556
Retroviral vectors for gene transfer into neuronal cells Mar 12, 2002 Abandoned
Array ( [id] => 7405713 [patent_doc_number] => 20040105871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-03 [patent_title] => 'Compositions and methods for generating an immune response' [patent_app_type] => new [patent_app_number] => 10/093953 [patent_app_country] => US [patent_app_date] => 2002-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 76 [patent_figures_cnt] => 76 [patent_no_of_words] => 29682 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20040105871.pdf [firstpage_image] =>[orig_patent_app_number] => 10093953 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/093953
Compositions and methods for generating an immune response Mar 7, 2002 Abandoned
Array ( [id] => 7323976 [patent_doc_number] => 20040137599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Leporipox-based vector vaccines' [patent_app_type] => new [patent_app_number] => 10/471300 [patent_app_country] => US [patent_app_date] => 2003-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7904 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20040137599.pdf [firstpage_image] =>[orig_patent_app_number] => 10471300 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/471300
Leporipox-based vector vaccines Mar 6, 2002 Issued
Menu